Clinical Trial Update: A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of intravenous L-citrulline in steady-state sickle cell disease completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Suvankar Majumdar | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-03-07